Identifying high-dose opioid prescription risks using machine learning: A focus on sociodemographic characteristics
Journal of Opioid Management · 2025
DOI: 10.5055/jom.0924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Opioid Management, 2025. Verfasst von Olabode B Ogundele und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Data Science and Informatics (MUIDSI); Missouri Telehealth Network (MTN), University of Missouri, Columbia, Missouri. Hauptthemen laut MEDLINE: Machine Learning, Analgesics, Opioid, Practice Patterns, Physicians', Drug Prescriptions.
Abstract (Originalsprache)
Objective
The objective of this study was to leverage machine learning techniques to analyze administrative claims and socioeconomic data, with the aim of identifying and interpreting the risk factors associated with high-dose opioid prescribing.
Design
We applied six machine learning algorithms to a dataset integrating Medicaid claims from Missouri (2017-2021) and 2018 United States Census Bureau data. High-dose prescribing was defined as dosages ≥120 morphine milligram equivalent/day. SHapely Additive exPlanations methods were utilized to enhance model interpretability, ensuring transparent insights into the predictors of high-dose prescription risks.
Results
Our findings reveal that sociodemographic factors like age, race, and sex, along with socioeconomic variables such as percentages of veterans, disability, and primary care physicians (PCPs) per capita, have associations with high-dose prescription risks. Notably, higher percentage of veterans and PCPs per capita within counties correspond with increased high-dose prescriptions, while older age groups and patient sex also predict a greater risk.
Conclusion
This analysis underscores the significant influence of sociodemographic variables on high-dose opioid prescriptions. The interplay of these factors highlights the need for multifaceted public health strategies to address the underlying complexities of the opioid crisis. The integration of machine learning methods with traditional epidemiological techniques represents a promising approach for gaining a comprehensive understanding of intricate patterns not captured in traditional statistical analysis, thereby enabling effective mitigation of the opioid crisis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Data Science and Informatics (MUIDSI); Missouri Telehealth Network (MTN), University of Missouri, Columbia, Missouri.
- Institute for Data Science and Informatics (MUIDSI), University of Missouri, Columbia, Missouri.
- Department of Electrical Engineering and Computer Science; Institute for Data Science and Informatics (MUIDSI), University of Missouri, Columbia, Missouri.
- Biomedical Informatics, Biostatistics and Medical Epidemiology (BBME); Institute for Data Science and Informatics (MUIDSI), University of Missouri, Columbia, Missouri.
- Sisters of St. Mary (SSM) Health, St. Louis, Missouri.
- Department of Psychiatry, University of Missouri Kansas City (UMKC), Kansas City, Missouri.
Zitieren
APA
Ogundele, O. B., Dahu, B. M., Rao, P., Song, X., Haithcoat, T., Hameed, M., Burgess, D., Greever-Rice, T., & Becevic, M. (2025). Identifying high-dose opioid prescription risks using machine learning: A focus on sociodemographic characteristics. Journal of Opioid Management. https://doi.org/10.5055/jom.0924
Vancouver
Ogundele OB, Dahu BM, Rao P, Song X, Haithcoat T, Hameed M, et al. Identifying high-dose opioid prescription risks using machine learning: A focus on sociodemographic characteristics. Journal of Opioid Management. 2025. doi:10.5055/jom.0924
BibTeX
@article{Ogundele2025,
author = {Ogundele, Olabode B and Dahu, Butros M and Rao, Praveen and Song, Xing and Haithcoat, Timothy and Hameed, Mutiyat and Burgess, Douglas and Greever-Rice, Tracy and Becevic, Mirna},
title = {Identifying high-dose opioid prescription risks using machine learning: A focus on sociodemographic characteristics},
journal = {Journal of Opioid Management},
year = {2025},
doi = {10.5055/jom.0924}
}
EUVIMED